Free Trial

Zacks Research Analysts Lift Earnings Estimates for The Clorox Company (NYSE:CLX)

→ Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad)

The Clorox Company (NYSE:CLX - Free Report) - Zacks Research raised their Q1 2025 EPS estimates for Clorox in a report released on Tuesday, May 14th. Zacks Research analyst R. Lohia now forecasts that the company will post earnings of $1.34 per share for the quarter, up from their previous forecast of $1.07. The consensus estimate for Clorox's current full-year earnings is $5.83 per share.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, topping analysts' consensus estimates of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The business had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same period last year, the company posted $1.51 earnings per share. Clorox's quarterly revenue was down 5.3% compared to the same quarter last year.

Several other analysts have also issued reports on CLX. Wells Fargo & Company lowered their price target on shares of Clorox from $140.00 to $135.00 and set an "underweight" rating on the stock in a research report on Thursday, May 2nd. Jefferies Financial Group raised Clorox from an "underperform" rating to a "hold" rating and set a $145.00 price target for the company in a report on Tuesday, March 26th. DA Davidson reiterated a "neutral" rating and set a $162.00 price objective on shares of Clorox in a research note on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft cut their target price on Clorox from $155.00 to $151.00 and set a "hold" rating for the company in a research note on Wednesday, April 17th. Finally, Barclays decreased their price target on Clorox from $136.00 to $132.00 and set an "underweight" rating on the stock in a research report on Thursday, May 2nd. Four analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. According to data from MarketBeat.com, Clorox currently has an average rating of "Hold" and an average price target of $146.43.


Check Out Our Latest Report on Clorox

Clorox Stock Performance

Shares of Clorox stock traded down $1.50 on Thursday, reaching $136.91. 1,414,741 shares of the company traded hands, compared to its average volume of 1,261,837. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53. The firm has a market capitalization of $17.00 billion, a PE ratio of 71.71, a PEG ratio of 2.18 and a beta of 0.44. The company has a 50 day moving average of $146.67 and a 200 day moving average of $144.34. Clorox has a 52 week low of $114.68 and a 52 week high of $169.14.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 10th. Investors of record on Wednesday, April 24th were paid a $1.20 dividend. The ex-dividend date of this dividend was Tuesday, April 23rd. This represents a $4.80 annualized dividend and a dividend yield of 3.51%. Clorox's payout ratio is currently 248.71%.

Hedge Funds Weigh In On Clorox

Several institutional investors and hedge funds have recently modified their holdings of the stock. Fortitude Family Office LLC purchased a new stake in Clorox during the 4th quarter valued at $29,000. Venturi Wealth Management LLC lifted its holdings in shares of Clorox by 308.5% during the first quarter. Venturi Wealth Management LLC now owns 192 shares of the company's stock valued at $29,000 after purchasing an additional 145 shares in the last quarter. Northwest Financial Advisors bought a new stake in Clorox in the 4th quarter worth about $29,000. Core Wealth Advisors Inc. purchased a new position in Clorox in the 4th quarter worth about $29,000. Finally, First United Bank & Trust bought a new position in Clorox during the 4th quarter valued at about $31,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Company Profile

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Earnings History and Estimates for Clorox (NYSE:CLX)

Should you invest $1,000 in Clorox right now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Featured Articles and Offers

7 Must-Buy Stocks Under $20

7 Must-Buy Stocks Under $20

In this video, we highlight seven stocks under $20 that are worth a closer look.

Search Headlines: